BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 029892
(186 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3DM3|A Chain A, Crystal Structure Of A Domain Of A Replication Factor A
Protein, From Methanocaldococcus Jannaschii. Northeast
Structural Genomics Target Mjr118e
pdb|3DM3|B Chain B, Crystal Structure Of A Domain Of A Replication Factor A
Protein, From Methanocaldococcus Jannaschii. Northeast
Structural Genomics Target Mjr118e
pdb|3DM3|C Chain C, Crystal Structure Of A Domain Of A Replication Factor A
Protein, From Methanocaldococcus Jannaschii. Northeast
Structural Genomics Target Mjr118e
Length = 105
Score = 27.7 bits (60), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 17/44 (38%), Positives = 25/44 (56%), Gaps = 5/44 (11%)
Query: 90 LTAIFQGSV----SVLVFTRTSDFLGKLKSY-VREEDGVVILKL 128
+TA F+G V + F R +GKLKS+ VR+E G + + L
Sbjct: 15 MTATFEGEVISALPIKEFKRADGSIGKLKSFIVRDETGSIRVTL 58
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 26.6 bits (57), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 10/24 (41%), Positives = 18/24 (75%)
Query: 102 VFTRTSDFLGKLKSYVREEDGVVI 125
V+TR S FL ++S+ +EE+G+ +
Sbjct: 230 VYTRVSHFLPWIRSHTKEENGLAL 253
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 26.6 bits (57), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 10/24 (41%), Positives = 18/24 (75%)
Query: 102 VFTRTSDFLGKLKSYVREEDGVVI 125
V+TR S FL ++S+ +EE+G+ +
Sbjct: 230 VYTRVSHFLPWIRSHTKEENGLAL 253
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 26.6 bits (57), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 10/24 (41%), Positives = 18/24 (75%)
Query: 102 VFTRTSDFLGKLKSYVREEDGVVI 125
V+TR S FL ++S+ +EE+G+ +
Sbjct: 230 VYTRVSHFLPWIRSHTKEENGLAL 253
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 26.6 bits (57), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 10/24 (41%), Positives = 18/24 (75%)
Query: 102 VFTRTSDFLGKLKSYVREEDGVVI 125
V+TR S FL ++S+ +EE+G+ +
Sbjct: 230 VYTRVSHFLPWIRSHTKEENGLAL 253
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 26.6 bits (57), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 10/24 (41%), Positives = 18/24 (75%)
Query: 102 VFTRTSDFLGKLKSYVREEDGVVI 125
V+TR S FL ++S+ +EE+G+ +
Sbjct: 230 VYTRVSHFLPWIRSHTKEENGLAL 253
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 26.6 bits (57), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 10/24 (41%), Positives = 18/24 (75%)
Query: 102 VFTRTSDFLGKLKSYVREEDGVVI 125
V+TR S FL ++S+ +EE+G+ +
Sbjct: 230 VYTRVSHFLPWIRSHTKEENGLAL 253
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 26.6 bits (57), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 10/24 (41%), Positives = 18/24 (75%)
Query: 102 VFTRTSDFLGKLKSYVREEDGVVI 125
V+TR S FL ++S+ +EE+G+ +
Sbjct: 230 VYTRVSHFLPWIRSHTKEENGLAL 253
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.328 0.142 0.453
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 5,018,078
Number of Sequences: 62578
Number of extensions: 186535
Number of successful extensions: 1424
Number of sequences better than 100.0: 9
Number of HSP's better than 100.0 without gapping: 8
Number of HSP's successfully gapped in prelim test: 1
Number of HSP's that attempted gapping in prelim test: 1416
Number of HSP's gapped (non-prelim): 9
length of query: 186
length of database: 14,973,337
effective HSP length: 93
effective length of query: 93
effective length of database: 9,153,583
effective search space: 851283219
effective search space used: 851283219
T: 11
A: 40
X1: 15 ( 7.1 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.8 bits)
S2: 48 (23.1 bits)